2024. Management of hormonal therapy for the treatment of advanced hormone-dependent prostate cancer: A pharmacoeconomics assessment of the use of Degarelix – Firmagon® compared to generic triptorelin. ACTA MEDICA PERUANA. 28, 4 (May 2024), 188–193.